Educating travelers about malaria: Dealing with resistance and patient noncompliance

被引：1

作者：

Dardick, K ^{[1
]}

机构：

[1] Connecticut Travel Med, Storrs, CT 06268 USA

来源：

CLEVELAND CLINIC JOURNAL OF MEDICINE | 2002年 / 69卷 / 06期

关键词：

D O I：

10.3949/ccjm.69.6.469

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

Malaria is a risk to travelers in many parts of the world. Physicians need to tailor chemoprevention strategies to take into account resistance patterns. Patient education is important, especially for those travelers least likely to comply with prevention strategies. Most travelers who contract malaria do not become ill until they return home, so recognition and treatment are crucial.

引用

收藏

页码：469 / 479

页数：11

相关论文

共 48 条

[1] A community-based study of human immunodeficiency virus type 2 provirus load in a rural village in West Africa [J].

Ariyoshi, K ;

Berry, N ;

Wilkins, A ;

Ricard, D ;

Aaby, P ;

Naucler, A ;

Ngom, PT ;

Jobe, O ;

Jaffar, S ;

Dias, F ;

Tedder, RS ;

Whittle, H .

JOURNAL OF INFECTIOUS DISEASES, 1996, 173 (01) :245-248

[2] MEFLOQUINE METABOLISM BY HUMAN LIVER-MICROSOMES - EFFECT OF OTHER ANTIMALARIAL-DRUGS [J].

BANGCHANG, KN ;

KARBWANG, J ;

BACK, DJ .

BIOCHEMICAL PHARMACOLOGY, 1992, 43 (09) :1957-1961

[3] FORTNIGHTLY REVIEW - MALARIA PROPHYLAXIS - GUIDELINES FOR TRAVELERS FROM BRITAIN [J].

BRADLEY, DJ ;

WARHURST, DC .

BRITISH MEDICAL JOURNAL, 1995, 310 (6981) :709-714

[4] Long-term malaria chemoprophylaxis with mefloquine in Dutch marines in Cambodia [J].

Buma, APCCH ;

vanThiel, PPAM ;

Lobel, HO ;

Ohrt, C ;

vanAmeijden, EJC ;

Veltink, RL ;

Tendeloo, DCH ;

vanGool, T ;

Green, MD ;

Todd, GD ;

Kyle, DE ;

Kager, PA .

JOURNAL OF INFECTIOUS DISEASES, 1996, 173 (06) :1506-1509

[5] INTERACTIONS OF ATOVAQUONE WITH OTHER ANTIMALARIAL-DRUGS AGAINST PLASMODIUM-FALCIPARUM IN-VITRO [J].

CANFIELD, CJ ;

PUDNEY, M ;

GUTTERIDGE, WE .

EXPERIMENTAL PARASITOLOGY, 1995, 80 (03) :373-381

[6]

*CDCP, 2001, HLTH INF INT TRAV 20

[7]

*CDCP, 2001, MAL GEN INF

[8]

*CDCP, 2001, MMWR-MORBID MORTAL W, V50, P25

[9]

Centers for Disease C. and Prevention, 2001, MMWR-MORBID MORTAL W, V50, P19

[10]

Centers for Disease Control and Prevention (CDC), 2001, MMWR Morb Mortal Wkly Rep, V50, P597

← 1 2 3 4 5 →